Skip to main content
v2026.11,772 entries · CC-BY 4.0

Laser Capture Microdissection (LCM): Principle, Workflow, and Sample Prep for Molecular Analysis

How laser capture microdissection isolates a pure, spatially-defined cell population from a tissue section for downstream RNA-seq, proteomics, and genomic analysis, plus the workflow steps and degradation/fixation tradeoffs that determine whether it works.

Ask about Laser Capture Microdissection (LCM): Principle, Workflow, and Sample Prep for Molecular Analysis

Answers are drawn from this guide and the rest of the CASRAI corpus, with a link to every source.

Answers are AI-generated from CASRAI’s own published pages and can be wrong, so check the linked sources before relying on one; your question is logged without personal data — never sold, never used to train a third-party model — to show us what CASRAI is missing, so please do not type personal or confidential details. How we use this

Written and maintained by CASRAI Editorial Board

Last updated

Laser capture microdissection (LCM) is a technique for isolating a specific, targeted region or population of cells directly from a thin tissue section, under microscopic visualization, using a focused laser to excise the boundary the operator has traced. The defining feature is that the tissue’s original spatial and morphological context is preserved right up until the moment of excision — the cells being collected are known to have come from a specific location in a specific structure, not pooled or dissociated first and sorted afterward.

That distinction is what makes LCM useful for downstream molecular work: RNA-seq, proteomics, and genomic or epigenomic analysis run on a pure, spatially-defined population instead of a homogenized chunk of tissue that mixes together whatever cell types happened to be nearby. This guide covers the underlying principle, the standard bench workflow, why researchers reach for LCM specifically, and the technical tradeoffs — RNA/protein degradation risk and fixation method choice — that determine whether a given LCM experiment actually works.

The principle: excision before dissociation, not after

Most methods for isolating a specific cell type from a complex tissue — enzymatic dissociation followed by flow sorting or magnetic bead sorting, for example — break the tissue apart first and identify the target population afterward, using surface markers. That approach discards spatial information: once cells are in suspension, there is no way to say which cells were adjacent to which, or where in the tissue architecture a given cell sat.

LCM inverts that order. A thin tissue section is mounted, stained just enough to make histology visible, and viewed live under a microscope. The operator (or, on newer systems, image-recognition software) identifies and traces the boundary of the target region — a single cell, a cluster of cells, a specific histological structure, or a tumor region distinct from surrounding stroma — while it is still in its native spatial context. A focused laser then cuts along that traced boundary, and only the traced material is collected. Everything outside the boundary is left behind. The result is a population defined by where it actually was in the tissue, not by a marker profile applied after the fact.

This is complementary to, not a replacement for, single-cell dissociation methods — see single-cell sequencing for the marker-based alternative. LCM is the right tool when the research question depends on spatial location or histological identity (tumor vs. adjacent normal tissue, a specific cortical layer, a specific gland), and dissociation-based sorting is the right tool when the question depends on a defined marker panel across a larger cell number.

Standard LCM workflow

  1. Tissue sectioning onto a membrane slide. The tissue is cut into thin sections — typically in the single-digit-micron range — using a cryostat for fresh-frozen tissue or a standard microtome for FFPE (formalin-fixed, paraffin-embedded) tissue. The critical difference from routine histology is the slide itself: sections are mounted on a polymer membrane slide (commonly PEN, polyethylene naphthalate, or a similar plastic film bonded to a glass backing) rather than plain glass. The laser cuts through the membrane, not the glass, which is what allows the excised fragment to separate cleanly and be collected.
  2. Staining for visualization. The mounted section is stained just enough to make the target histology identifiable under the microscope — commonly a rapid H&E, cresyl violet, toluidine blue, or an immunostain when the target population is defined by a specific marker rather than morphology alone. Staining protocols for LCM are deliberately abbreviated relative to routine histopathology staining, and reagents are typically nuclease-free when RNA is the downstream target, because every extra minute between tissue exposure and completed dissection is time for degradation to occur.
  3. Laser microdissection. Under live microscope visualization, the target region is traced and the laser cuts the membrane along that boundary. Commercial platforms differ in the exact optical and collection mechanism — some cut with an ultraviolet laser and collect by gravity or an adhesive cap, others add an infrared step to catapult or pulse the cut fragment into a collection vessel — but the underlying principle (visualize, trace, cut, collect) is the same across systems.
  4. Collection. The excised membrane-plus-tissue fragment is collected directly into a tube, cap, or multiwell device, typically positioned to catch the fragment immediately below or above the section, often straight into lysis or extraction buffer so the sample moves directly into nucleic acid or protein extraction without an intermediate handling step.

Why it matters: molecular analysis on a defined population, not a homogenate

A standard tissue homogenate for RNA-seq, mass spectrometry, or DNA sequencing represents an average across every cell type present in the sampled tissue — tumor and stroma, neurons and glia, epithelium and the immune infiltrate around it, all pooled together. That averaging can hide or dilute a signal that is actually confined to one specific population. LCM removes that confound by supplying a molecularly pure, spatially-defined input:

  • Transcriptomics — RNA extracted from an LCM-isolated population reflects the expression profile of that population specifically, not an average across the tissue. See RNA-seq: experimental design through analysis for how that input feeds into library prep and analysis once extracted.
  • Proteomics — mass spectrometry run on an LCM-isolated population avoids the same averaging problem for protein abundance and post-translational modification data; see mass spectrometry proteomics: DDA/DIA, sample prep, and run QC for how low-input, LCM-derived samples affect acquisition and QC choices downstream.
  • Genomics — isolating tumor cells away from adjacent normal or stromal tissue before sequencing avoids diluting a somatic variant’s allele frequency with wild-type signal from surrounding non-tumor cells, which matters directly for variant-calling sensitivity.

This is why LCM shows up specifically in cancer research (isolating tumor from stroma and immune infiltrate), neuroscience (isolating a specific cortical layer, nucleus, or neuron subtype), and developmental biology (isolating a specific anatomical structure at a defined stage) — cases where the biology being studied is inseparable from where the cells physically are.

Key technical considerations

RNA and protein degradation risk

LCM extends the time a tissue section spends unfixed and exposed relative to routine histology, and that window is where degradation happens. In fresh-frozen sections, the dominant risk is endogenous RNase activity in the tissue itself, which remains active until the section is properly dehydrated or fixed. In formalin-fixed sections, the fixation chemistry itself is the larger factor: formaldehyde crosslinks and fragments RNA and protein, so the damage is largely already done before dissection even starts. In practice, dissection is generally completed within about an hour of staining to limit further degradation, staining protocols use an ethanol dehydration series rather than aqueous steps specifically to inactivate RNases faster, and reagents are kept nuclease-free throughout. Working on ice or with a cold stage, and minimizing the number of sections staged at once, are standard mitigations rather than optional extras.

Fixation method tradeoffs

The choice between fresh-frozen and FFPE tissue is made well before LCM starts, but it determines what’s achievable during and after it:

  • Fresh-frozen (OCT-embedded, cryosectioned): gives the best RNA and protein integrity, since there is no crosslinking chemistry involved — but requires continuous cold-chain storage (typically -80°C), tissue morphology is comparatively harder to read for fine histological detail, and endogenous RNase activity is a live risk until the section is stabilized.
  • FFPE: gives superior histological detail and stores stably at room temperature, which is why the overwhelming majority of archived, retrospective clinical tissue exists in this form — but formalin crosslinking fragments nucleic acids and proteins, so downstream extraction needs chemistries and kits specifically designed for degraded, crosslinked FFPE input, and sequencing or mass spec platforms need to tolerate shorter fragment lengths and lower effective yield than fresh-frozen input would give.

Neither option is strictly better — the choice trades RNA/protein integrity against morphological clarity and archival practicality, and which one matters more depends on whether the study needs retrospective archival material or can be designed around prospective fresh-frozen collection.

Section thickness and collection yield

Thinner sections improve the purity of what gets collected, since a thicker section increases the chance that cells just above or below the traced boundary in the z-axis get pulled along with the target. That purity comes at the cost of yield: thinner sections contain less material per cut, so reaching enough input mass for a given downstream assay often means collecting from more sections or more fields, which is part of why LCM is frequently paired with library-prep and mass spec protocols specifically adapted for low-input samples rather than standard-input protocols scaled down.

Frequently asked questions

What is laser capture microdissection used for?

Isolating a specific, spatially-defined cell population or structure from a tissue section — for example, tumor cells apart from surrounding stroma, a specific brain region or neuron type, or a specific gland or duct — so that RNA-seq, proteomics, or genomic analysis can be run on that population specifically rather than on a mixed tissue homogenate.

How is LCM different from single-cell dissociation and sorting?

Dissociation-based methods break the tissue apart first and identify the target population afterward using surface markers, which discards spatial context. LCM identifies and excises the target while it is still in its original position in an intact tissue section, so the result retains a known spatial and histological origin. See single-cell sequencing for the dissociation-based alternative.

Can LCM be performed on FFPE tissue?

Yes — FFPE is a standard input for LCM and is the more commonly archived tissue format, but formalin crosslinking fragments RNA and protein, so downstream extraction requires FFPE-specific extraction chemistry and analysis platforms tolerant of degraded, shorter-fragment input, unlike fresh-frozen tissue.

How long can a stained section sit before RNA quality is compromised?

As a working rule, dissection is generally completed within about an hour of staining to limit further RNA degradation, with the exact tolerance depending on the tissue type, fixation method, and staining protocol used.

What kind of slide does LCM require?

A polymer membrane slide (commonly a PEN or similar plastic film bonded to a glass backing), not a standard glass slide — the laser cuts through the membrane itself, which is what allows the targeted fragment to separate cleanly from the rest of the section during collection.

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →

Regulatory Radar

Stop finding out after the fact

$29/month, cancel anytime. Daily digest updates from our analysis, a dashboard holding the same items, and a cited assistant for everything they raise.

  • Federal Register, Federal Register+, Grants.gov, Regulations.gov, NSF News, UKRI, plus CASRAI’s own published content.
  • 44,322 indexed passages, and every answer cites the ones it drew on.